Association of Low‐Density Lipoprotein Cholesterol Levels During Statin Treatment With Cardiovascular and Renal Outcomes in Patients With Moderate Chronic Kidney Disease

Association of Low‐Density Lipoprotein Cholesterol Levels During Statin Treatment With Cardiovascular and Renal Outcomes in Patients With Moderate Chronic Kidney Disease

Background The benefit of low‐density lipoprotein cholesterol (LDL‐C) levels in chronic kidney disease populations remains unclear. This study evaluated the cardiovascular and renal outcomes in patients with stage 3 chronic kidney disease with different LDL‐C levels during statin treatment. Methods...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: Chieh‐Li Yen, Pei‐Chun Fan, Cheng‐Chia Lee, Jia‐Jin Chen, George Kuo, Yi‐Ran Tu, Pao‐Hsien Chu, Hsiang‐Hao Hsu, Ya‐Chung Tian, Chih‐Hsiang Chang
Materiálatiipa: Artihkal
Giella:English
Almmustuhtton: Wiley 2022-10-01
Ráidu:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Fáttát:
cardiovascular disease
chronic kidney disease
low‐density lipoprotein cholesterol
statin
stroke
Liŋkkat:https://www.ahajournals.org/doi/10.1161/JAHA.122.027516

Interneahtta

https://www.ahajournals.org/doi/10.1161/JAHA.122.027516

Geahča maid